| Efficacy and Safety Study of Inhaled CVT 301 in Parkinson's Disease Patients for Treatment of OFF Episodes (NCT01777555) | Acorda Therapeutics | 2013-04-01 |
| Pilot Study: Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Prevention (NCT01780974) | Oregon Health and Science University | 2013-04-01 |
| Safety and Tolerability of Oral Polyethylene Glycol (PEG 3350) Solution in Participants With Constipation (MK-8114-003) (NCT01885104) | Bayer | 2013-04-01 |
| Influence of Progesterone Administration on Drug-Induced QT Interval Lengthening (NCT01929083) | Indiana University | 2013-04-01 |
| A Multicenter Trial of Sprifermin (AS902330 [Recombinant Human Fibroblast Growth Factor-18]) or Placebo After Microfracture Surgery for Cartilage Injury of the Knee (NCT01689337) | EMD Serono | 2013-04-01 |
| Phase 1b/2a Unblinded Study of Responses in Premenopausal Women With HSDD to Lorexys Evaluating Efficacy and Safety (NCT01857596) | S1 Biopharma, Inc. | 2013-04-01 |
| A Phase II Study of Carfilzomib in Relapsed Waldenström's Macroglobulinemia (WM) IST-CAR-531 (NCT01813227) | Hackensack Meridian Health | 2013-04-01 |
| Low Cost Biological Lung Volume Reduction Therapy for Advanced Emphysema (NCT02107209) | Mansoura University | 2013-04-01 |
| Treatment CLI Nonrevascularizable Lower Limb With Cell Therapy (NCT01824069) | Instituto de Investigación Hospital Universitario La Paz | 2013-04-01 |
| Periodontal Therapy in a Primary Prevention of Cardiovascular Disease (NCT02081976) | Macmillan Research Group UK | 2013-04-01 |
| Prospective Study of the Influence of the Diffuse Noxious Inhibitory Controls of the Pain on the Efficacy of Milnacipran in Fibromyalgia Therapy (NCT01747044) | University Hospital, Clermont-Ferrand | 2013-04-01 |
| Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women (NCT01889199) | University of California, Los Angeles | 2013-04-01 |
| A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy to Patients With Non-Small Cell Lung Cancer (NCT01792479) | BIND Therapeutics | 2013-04-01 |
| Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine or Chloroquine/Azithromycin Prophylaxis (NCT01783340) | Radboud University Medical Center | 2013-04-01 |
| Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT) (NCT01800968) | Duke University | 2013-04-01 |
| The Effect of Pollen Season on Subcutaneous Allergen Immunotherapy Reactions (NCT01878929) | University Hospitals Cleveland Medical Center | 2013-04-01 |
| Neoadjuvant Therapy of Icotinib in Epidermal Growth Factor Receptor Mutated NSCLC Patients (NCT01843647) | Betta Pharmaceuticals Co., Ltd. | 2013-04-01 |
| Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C (NCT01821625) | University of Texas Southwestern Medical Center | 2013-04-01 |
| Antimicrobial Catheter Lock Solution for the Treatment of Central Line Associated Bloodstream Infection (CLABSI) (NCT01539343) | M.D. Anderson Cancer Center | 2013-04-01 |
| Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer (NCT01877187) | Yale University | 2013-04-01 |
| Efficacy and Safety Study of F373280 (NCT01831856) | Pierre Fabre Medicament | 2013-04-01 |
| Safety, Tolerability and Efficacy of Weekly TV-1106 in Adults With Growth Hormone Deficiency (NCT01811576) | Teva Branded Pharmaceutical Products R&D, Inc. | 2013-03-31 |
| BKM120 for Patients With PI3K-activated Tumors (NCT01833169) | Novartis Pharmaceuticals | 2013-03-29 |
| An Efficacy and Safety Study of Two Doses of Intra-Articular Ampion Injection for Pain of Osteoarthritis of the Knee (NCT01839331) | Ampio Pharmaceuticals. Inc. | 2013-03-29 |
| An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults (NCT01753193) | MedImmune LLC | 2013-03-28 |
| An Efficacy and Safety Study of SRM003 in the Treatment of Subjects Undergoing Placement of an Arteriovenous Graft to Facilitate Hemodialysis Access (NCT01806584) | Shire | 2013-03-28 |
| Autologous Cell Therapy for Treatment of Fecal Incontinence (NCT01600755) | Cook MyoSite | 2013-03-28 |
| A Study to Investigate the Effect of ASP1517 After Intermittent Oral Dosing in Dialysis Chronic Kidney Disease Patients With Anemia Compared With Darbepoetin as a Reference Drug (NCT01888445) | Astellas Pharma Inc | 2013-03-28 |
| Reduced Intensity Haploidentical BMT for High Risk Solid Tumors (NCT01804634) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2013-03-27 |
| Brachytherapy for Recurrent Prostate Cancer (NCT01956058) | Centre Georges Francois Leclerc | 2013-03-26 |
| QUILT-3.006 for Recurrent Medullary Thyroid Cancer (NCT01856920) | NantCell, Inc. | 2013-03-26 |
| An Efficacy and Safety Study of SRM003 in the Treatment of Subjects Undergoing Creation of an Arteriovenous Fistula to Facilitate Hemodialysis Access (NCT01806545) | Shire | 2013-03-26 |
| Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer (NCT01724866) | Spectrum Pharmaceuticals, Inc | 2013-03-25 |
| Phase I/II NabPaclitaxel, Paclitaxel&Carboplatin w RTX Followed by Consolidation in Patients w Favorable Prognosis Inoperable Stage IIIA/B NSCLC (NCT01757288) | University of Texas Southwestern Medical Center | 2013-03-25 |
| Efficacy and Safety of Novel Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis (NCT05488990) | Lipidor AB | 2013-03-25 |
| Study Efficacy and Safety of INC280 in Patients With Advanced Hepatocellular Carcinoma. (NCT01737827) | Novartis Pharmaceuticals | 2013-03-25 |
| Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery (NCT01708941) | National Cancer Institute (NCI) | 2013-03-25 |
| Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer (NCT01810913) | National Cancer Institute (NCI) | 2013-03-22 |
| Intervention for Symptom Burden During Maintenance Therapy for Multiple Myeloma (NCT01793051) | M.D. Anderson Cancer Center | 2013-03-22 |
| Fluoroscopy or 3-D Roadmap Imaging Software for Liver Tumor Treatment (NCT01818440) | National Institutes of Health Clinical Center (CC) | 2013-03-21 |
| Study of LY2835219 for Mantle Cell Lymphoma (NCT01739309) | Eli Lilly and Company | 2013-03-20 |
| Brentuximab Vedotin With or Without Nivolumab in Treating Patients With Relapsed or Refractory CD30+ Lymphoma (NCT01703949) | University of Washington | 2013-03-20 |
| Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors (NCT02100891) | Monica Thakar | 2013-03-20 |
| Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients (NCT01784068) | Novartis Pharmaceuticals | 2013-03-19 |
| Phase II Trial of First-line Doxycycline for Ocular Adnexal Marginal Zone Lymphoma Treatment (NCT01820910) | International Extranodal Lymphoma Study Group (IELSG) | 2013-03-19 |
| Allogeneic Cord Blood Cells for Adults With Severe Acute Contusion Spinal Cord Injury (NCT04331405) | Sklifosovsky Institute of Emergency Care | 2013-03-18 |
| Long-Term Safety Of PF-00547659 In Ulcerative Colitis (NCT01771809) | Shire | 2013-03-18 |
| Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis (NCT01500551) | Pfizer | 2013-03-18 |
| Best Systemic Therapy or Best Systemic Therapy (BST) Plus Definitive Treatment (Radiation or Surgery) (NCT01751438) | M.D. Anderson Cancer Center | 2013-03-18 |
| Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease (NCT01752985) | Bristol-Myers Squibb | 2013-03-18 |
| High-Dose Deferoxamine in Intracerebral Hemorrhage (NCT01662895) | Beth Israel Deaconess Medical Center | 2013-03-18 |
| Focal Therapy Using HIFU for Localised Prostate Cancer (NCT02016040) | Jewish General Hospital | 2013-03-17 |
| A Phase 2, Safety, Tolerability, and Efficacy Study of PD 0360324 in Chronic Pulmonary Sarcoidosis (NCT01732211) | Pfizer | 2013-03-15 |
| Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy (NCT01737398) | Ionis Pharmaceuticals, Inc. | 2013-03-15 |
| TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer. (NCT01711658) | Radiation Therapy Oncology Group | 2013-03-15 |
| Evaluating the Safety and Tolerability of Etravirine in HIV-1 Infected Infants and Children (NCT01504841) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-03-14 |
| Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacodynamics of Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies (NCT01799889) | Gilead Sciences | 2013-03-14 |
| A Phase II Study of Increased-Dose Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer (NCT01637402) | Terence Friedlander, MD | 2013-03-13 |
| Trial to Assess the Efficacy of Midostaurin (PKC412) in Patients With c-KIT or FLT3-ITD Mutated t(8;21) AML (NCT01830361) | Technische Universität Dresden | 2013-03-13 |
| Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative Neoplasm (NCT01787487) | M.D. Anderson Cancer Center | 2013-03-13 |
| Idebenone for Primary Progressive Multiple Sclerosis (NCT01854359) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-03-12 |
| Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma (NCT01811368) | Joseph Tuscano | 2013-03-12 |
| Safety Study of Allogeneic Mesenchymal Precursor Cell Infusion in Myocardial Infarction (NCT01781390) | Mesoblast, Inc. | 2013-03-11 |
| Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients Renal Cell Carcinoma (NCT01806064) | Tracon Pharmaceuticals Inc. | 2013-03-08 |
| Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma (NCT01771107) | National Cancer Institute (NCI) | 2013-03-08 |
| Revacept in Symptomatic Carotid Stenosis (NCT01645306) | AdvanceCor GmbH | 2013-03-08 |
| Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer (NCT01698918) | Novartis Pharmaceuticals | 2013-03-07 |
| 5 Fraction Stereotactic Body Radiation Therapy for Oligometastases Regimen, for Extra-Cranial Oligometastases (NCT01761929) | University Health Network, Toronto | 2013-03-07 |
| A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas (NCT01782313) | Northwestern University | 2013-03-06 |
| Treatment of Newly Diagnosed Moderate or Severe Chronic Graft-versus-host Disease With Prednisone and Everolimus (NCT01862965) | Universitätsklinikum Hamburg-Eppendorf | 2013-03-06 |
| A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients (NCT01780844) | Astellas Pharma Global Development, Inc. | 2013-03-05 |
| Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia (NCT01319981) | M.D. Anderson Cancer Center | 2013-03-05 |
| Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas (NCT01805037) | Northwestern University | 2013-03-05 |
| Treatment of PAD by Platelet Lysate for Therapeutic Angiogenesis (NCT02941419) | University of Jordan | 2013-03-05 |
| Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC) (NCT01672853) | Gilead Sciences | 2013-03-04 |
| The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer (NCT01790126) | Aragon Pharmaceuticals, Inc. | 2013-03-04 |
| 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy (NCT01806675) | Sanjiv Sam Gambhir | 2013-03-04 |
| AZD9291 First Time In Patients Ascending Dose Study (NCT01802632) | AstraZeneca | 2013-03-04 |
| Trastuzumab & Pertuzumab Followed by T-DM1 in MBC (NCT01835236) | Swiss Cancer Institute | 2013-03-03 |
| Regulatory T Cells in Type 1 Diabetes Patients Treated With IL-2 (NCT01827735) | Cambridge University Hospitals NHS Foundation Trust | 2013-03-01 |
| Ofatumumab Induction and Maintenance in Elderly Patients With Poor Risk CLL in the Context of Allogeneic Transplantation (NCT01809847) | Technische Universität Dresden | 2013-03-01 |
| LEVANT Japan Clinical Trial (NCT01816412) | C. R. Bard | 2013-03-01 |
| Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild Asthma (NCT01804218) | Invion, Inc. | 2013-03-01 |
| Effects of Alpha-1 Antagonist, Stress and Relaxation on Anorectal Functions (NCT01834729) | Mayo Clinic | 2013-03-01 |
| Medico-economical Assessment of Telemedicine During Chronic Diabetes-related Foot Wound Management (NCT01814267) | University Hospital, Grenoble | 2013-03-01 |
| Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant (NCT01744223) | Bellicum Pharmaceuticals | 2013-03-01 |
| Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular Melanoma (NCT01814046) | National Cancer Institute (NCI) | 2013-03-01 |
| NOV120101 (Poziotinib) for 1st Line Monotherapy in Patients With Lung Adenocarcinoma (NCT01819428) | National OncoVenture | 2013-03-01 |
| 3D Augmented Reality Mirror Visual Feedback Applied to the Treatment of Unilateral Upper Extremity Neuropathic Pain. (NCT02582216) | Erasme University Hospital | 2013-03-01 |
| To Investigate the Safety, Pharmacodynamics and Effect on Allergic Reactivity of the Toll-like Receptor 7 (TLR7) Agonist GSK2245035 in Subjects With Respiratory Allergies (NCT01788813) | GlaxoSmithKline | 2013-03-01 |
| Safety and Efficacy of Donor T-lymphocytes Depleted ex Vivo of Host Alloreactive T-cells (ATIR) in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor (NCT01794299) | Kiadis Pharma | 2013-03-01 |
| Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease (NCT01810185) | Santa Barbara Cottage Hospital | 2013-03-01 |
| Comparison Between Two Coronally Positioned Flap With Connective Tissue (NCT01814592) | Universidad El Bosque, Bogotá | 2013-03-01 |
| Phase II Trial of Tivozanib in Advanced Hepatocellular Cancer (NCT01807156) | Emory University | 2013-03-01 |
| Weekly Vitamin D in Pediatric IBD (NCT02076750) | Emory University | 2013-03-01 |
| Phase 2 Study of the Monoclonal Antibody MGAH22 (Margetuximab) in Patients With Relapsed or Refractory Advanced Breast Cancer (NCT01828021) | MacroGenics | 2013-03-01 |
| Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia (NCT01842672) | New York Medical College | 2013-03-01 |
| A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Participants With Squamous Lung Cancer (NCT01788566) | Eli Lilly and Company | 2013-03-01 |
| Pilot Study of Ustekinumab for Subjects With Chronic Atopic Dermatitis (NCT01806662) | Rockefeller University | 2013-03-01 |
| Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery (NCT01802320) | National Cancer Institute (NCI) | 2013-03-01 |